Articles published by Organovo, Inc.
Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting
November 20, 2024
From Organovo, Inc.
Via GlobeNewswire
Tickers
ONVO
Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis Congress
January 09, 2024
From Organovo, Inc.
Via GlobeNewswire
Tickers
ONVO
Organovo Provides Timing for Release of FXR314 Phase 2 NASH Results
December 06, 2023
From Organovo, Inc.
Via GlobeNewswire
Tickers
ONVO
Organovo Highlights FXR314 Combination Therapy Potential and Plan
November 08, 2023
From Organovo, Inc.
Via GlobeNewswire
Tickers
ONVO
Organovo to Participate in the H.C. Wainwright Global Investment Conference
September 08, 2023
From Organovo, Inc.
Via GlobeNewswire
Tickers
ONVO
Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data
August 23, 2023
From Organovo, Inc.
Via GlobeNewswire
Tickers
ONVO
Organovo Announces Target Validation Ahead of Schedule, Accelerating Timeline for First Crohn’s Disease Drug Candidates
November 15, 2022
From Organovo, Inc.
Via GlobeNewswire
Tickers
ONVO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.